Clinical Trials Directory

Trials / Completed

CompletedNCT03243630

Effects of Flavors on Nicotine Reinforcement in Smokers

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
26 (actual)
Sponsor
Yale University · Academic / Other
Sex
All
Age
18 Years – 30 Years
Healthy volunteers
Not accepted

Summary

To examine the acute reinforcing effects of menthol, a fruit flavor (green apple) or a fruit flavor plus menthol, alone or in combination with nicotine in smokers. Flavors will be administered by inhalation via electronic cigarettes (e-cigarettes) and nicotine will be administered intravenously. The reinforcing drug effects will be measured with the drug effects questionnaire (DEQ).

Detailed description

This is a proposed double-blind, crossover study that enrolls young adult smokers who prefer menthol cigarettes. The study will consist of an adaptation session and three test sessions. In the adaptation session, participants will practice using the e-cigarette by sampling the flavors to be used in the test sessions. The test sessions will be performed following overnight abstinence from tobacco. Across the three test sessions, participants will be assigned to a random sequence of the three different e-cigarette conditions: menthol, green apple or menthol plus green apple, a different flavor condition for each test session. In each test session, just after the assigned flavor is delivered via the e-cigarette, participants will receive a random order of one intravenous delivery of saline, and two intravenous deliveries of nicotine (3.6 mcg/kg and 7 mcg/kg or 0.25 mg/70 kg and 0.5 mg/70kg), one hour apart. The test sessions will be performed at least 24 hours apart to minimize carryover nicotine effects. The main outcome measure will be subjective drug effects as measured with the Drug Effects Questionnaire (DEQ). Other outcomes include cardiovascular measures, cognitive performance, and self-report measures of nicotine withdrawal and craving. Cardiovascular measures include heart rate, systolic and diastolic blood pressure. Cognitive performance will be assessed with the Stroop test, mathematical processing test (MPT), and continuous performance test (CPT). Nicotine withdrawal measures will be measured with the Minnesota Nicotine Withdrawal Symptom Checklist (M-NWSC) and the Brief Questionnaire on Smoking Urges (BQSU).

Conditions

Interventions

TypeNameDescription
DRUGIV nicotineSubjects in each arm will receive three infusions in a random order one hour apart. The infusions will be saline, 0.25mg/70kg and 0.5mg/70kg
DRUGMenthol flavorAmerican e-liquids' menthol flavor used in e-cigarettes will be used as the placebo comparator
DRUGgreen applegreen apple will be added to the menthol flavor
DRUGgreen apple and mentholmenthol and green apple will be the active intervention

Timeline

Start date
2018-04-23
Primary completion
2018-12-19
Completion
2019-01-31
First posted
2017-08-09
Last updated
2020-12-03
Results posted
2020-11-13

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03243630. Inclusion in this directory is not an endorsement.